Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

MERIDIAN BIOSCIENCE, INC.

United States·US-MF-000044096

Last updated September 17, 2026

Information

Country
United States
Address
3471, River Hills Drive, Cincinnati (OHIO), United States
LinkedIn
—
Facebook
—
Phone
+1 513.673.8109
PRRC Contact
Susan Bogar
EUDAMED SRN
US-MF-000044096
FDA FEI Number
1524213
DUNS Number
—

Catalogue (235)

Page 5 of 5
DeviceModel / ReferenceRegistriesClassStatus
Illumigene Mycoplasama Dna Amplification Assay, And Illumigene Mycoplasma External Controls Kit K123423
FDA 510(k)
Class IIActive
Immunocard Stat Campy, Model 751530 K090700
FDA 510(k)
Class IActive
Curian Campy K210976
FDA 510(k)
Class IActive
Curian® Shiga Toxin K222829
FDA 510(k)
Class IActive
Tru Legionella K113190
FDA 510(k)
Class IIActive
PREMIER Platinum HpSA PLUS K182559
FDA 510(k)
Class IActive
Illumigene C. Difficile, Illumipro-10 And Illumigene C. Difficile External Control Kit, Models 280050, 610172, 279920 K100818
FDA 510(k)
Class IActive
ImmunoCard STAT! HpSA K153661
FDA 510(k)
Class IActive
Immunocard Stat! E. Coli O157 Plus K023599
FDA 510(k)
Class IActive
TRU Legionella K163273
FDA 510(k)
Class IIActive
Illumigene Group B Streptococcus Carrot Broth Claim K121044
FDA 510(k)
Class IActive
Curian HpSA, Curian Analyzer K192817
FDA 510(k)
Class IActive
Tru Flu K071657
FDA 510(k)
Class IIActive
Illumigene Group B Streptococcus , External Control Kit K112125
FDA 510(k)
Class IActive
Premier Platinum Hpsa Plus, Models 601396, 601480 K053335
FDA 510(k)
Class IActive
Immunocard Toxins A & B, Model 712050 K041003
FDA 510(k)
Class IActive
Tru Flu, Model 751230 K092553
FDA 510(k)
Class IIActive
Premier HpSA Flex (619096) K230901
FDA 510(k)
Class IActive
illumigene Pertussis DNA Amplification Assay K152285
FDA 510(k)
Class IIActive
Tru Flu K133714
FDA 510(k)
Class IIActive
Tru Rsv K071101
FDA 510(k)
Class IActive
Immunocardstat Hpsa K032222
FDA 510(k)
Class IActive
Immunocard Stat! Ehec, Model 751630 K062546
FDA 510(k)
Class IActive
Premier C. Difficile Gdh K110620
FDA 510(k)
Class IActive
illumigene Mycoplasma DNA Amplification Assay K152800
FDA 510(k)
Class IIActive
Immunocard Stat! Flu A & B K041626
FDA 510(k)
Class IIActive
Streptococcus App. Serological Reagents K122019
FDA 510(k)
Class IActive
Immunocard Stat! Rsv Model #750630 K041445
FDA 510(k)
Class IActive
Illumigene C. Difficile, And Illumipro-10 K110012
FDA 510(k)
Class IActive
Alethia 610189
EUDAMEDFDA UDI
Class AActive
Para-Pak® C&S 900612
EUDAMEDFDA UDI
Class AActive
Para-Pak® SVT 901612
EUDAMEDFDA UDI
Class AActive
Curian Analyzer 610190
EUDAMEDFDA UDI
Class AActive
Para-Pak® 10% Formalin 900412
EUDAMEDFDA UDI
Class AActive
Breath Tek Ubtfor H. Pylori Kit P100025
FDA PMA
Class IIIActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (22)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Dec 5, 2025Z-1019-2026—open, classified

The affected lots show a decline in performance over time, which may lead to false-negative results.

Oct 7, 2025Z-0569-2026—open, classified

The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.

Oct 7, 2025Z-0568-2026—open, classified

The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.

Oct 19, 2023Z-0521-2024—open, classified

Due to a manufacturing defect, certain Para-Pak vials may be at risk for leakage.

Oct 19, 2023Z-0520-2024—open, classified

Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to biological hazards associated with direct contact with the patient specimen.

Oct 19, 2023Z-0519-2024—open, classified

Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to biological hazards associated with direct contact with the patient specimen.

Dec 15, 2022Z-1008-2023—open, classified

Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2

Jun 22, 2022Z-1479-2022—open, classified

When a run is aborted, the cooling period protection does not occur and the user is able to open the lid prior to the completion of the cooling period, exposing the user to heated instrument components. Incidental contact with heated instrument components may result in an injury such as minor burns.

Feb 15, 2022Z-0836-2022—open, classified

The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in false-positive or indeterminate results.

Apr 8, 2021Z-1540-2021—terminated

Emergency Use Application (EUA) application withdrawn as false negative results reported

Apr 8, 2021Z-1541-2021—terminated

Emergency Use Application (EUA) application withdrawn as false negative results reported

Feb 8, 2021Z-1299-2021—terminated

Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause of patient symptoms. The appropriate treatment may not be administered, and symptoms may progress. Additional evaluations will be completed and documented within the associated Health Hazard Evaluation.

Dec 17, 2018Z-0732-2019—terminated

An enzyme reagent included in the kit is not maintaining stability through claimed product expiration, resulting in the potential for false negative results when tested with patient specimens and the positive control.

Nov 8, 2016Z-1033-2017—terminated

Internal testing has demonstrated that the indicated kit lots produce false positive results when tested with some broth specimens.

Apr 22, 2014Z-1941-2014—terminated

Illumipro-10 instruments may have Block B chambers operating at an incorrect temperature as a result of incorrect temperature calibration.

Oct 10, 2011Z-0203-2012—terminated

Internal testing has shown that the indicated kits produce false negative results when tested with some direct stool specimens. These false negative reactions are not observed for all devices tested, however, the rate of occurrence will likely impact clinical sensitivity as defined by product registration and associated instructions for use.

Jun 2, 2006Z-1203-06—terminated

The product may produce non-specific reactions with negative specimens and/or the negative control reagent. These non-specific interactions may result in increased invalid test rates and/or positivity rates.

Sep 23, 2003Z-0062-04—terminated

The kits were packaged with incorrect dispensing pipettes.

Jun 18, 2003Z-1127-03—terminated

The Low Positive Standard kit component is losing potency that may result in false positive test results.

Dec 26, 2002Z-0465-03—terminated

Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.

Dec 26, 2002Z-0463-03—terminated

Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.

Dec 26, 2002Z-0464-03—terminated

Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.